Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial - Authors' reply. Chow PKH, Hack SP, Spahn JH, Yopp AC, et al. Lancet 2024;404:657-658.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chow PKH, Hack SP, Spahn JH, Yopp AC, et al. Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial - Authors' reply. Lancet 2024;404:657-658.
PMID: 39153815